Text full multimedia monochrome

First time here?

Find out more about how The Lecture List works.

Coronavirus situation update

Our lecture organisers may or may not have had time to update their events with cancellation notices. Clearly social gatherings are to be avoided and that includes lectures. STAY AT HOME FOLKS, PLEASE.

Help!

Find out what you can do to keep The Lecture List online

Strategies for commercial success of biosimilars in an increasingly crowded market place

This Euroscicon biosimilars conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, biosimilar products to the market place.


Whilst biopharmaceuticals remain a major component of the global therapeutics market, the ever expanding portfolio of products losing patent protection and with increasing healthcare costs remaining a poignant issue, the opportunity for development of competing, follow on biologics remains an attractive proposition for both Biotech and Pharma companies alike. This Euroscicon biosimilars conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, biosimilar products to the market place.


Speaker(s):

Dr Dave Simpson | talks

 

Date and Time:

19 April 2012 at 9:00 am

Duration:

Full Day

 

Venue:

The Penridge Suite
470 Bowes Road
London
N11 1NL

http://www.lifescienceevents.com
Show map

Organised by:

Euroscicon
See other talks organised by Euroscicon...

 

Tickets:

See http://www.regonline.co.uk/biosimilars2012

Available from:

Additional Information:

http://www.regonline.co.uk/biosimilars2012

Register to tell a friend about this lecture.

Comments

If you would like to comment about this lecture, please register here.



 

Any ad revenue is entirely reinvested into the Lecture List's operating fund